We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Rigaku Announces Reorganization

Rigaku Announces Reorganization

Rigaku Announces Reorganization

Rigaku Announces Reorganization

Read time:

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Rigaku Announces Reorganization "

First Name*
Last Name*
Email Address*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Rigaku has announced reorganization whereby the various operating companies and divisions of Rigaku, serving markets external to Japan and its core sales territories, began to operate as a single company.

As of September 1, 2005, Rigaku Americas Corporation (RAC) became the operating entity in charge of North America.

Over the last decade, Rigaku has acquired or founded a number of companies in order to develop a technology portfolio capable of sustained innovation for core markets.

During this period of high growth, the new additions retained their individual company identities.

With key capabilities now in place, top level integration will maximize the quality of solutions available to our customers while expediting the rollout of new advances.

Henceforth, all marketing and advertising material will brand the company solely as “Rigaku."

The new, combined organization (RAC) includes: Rigaku/MSC, Osmic, RoboDesign, Molecular Images, Electronic Imaging Technologies, Molecular Metrology, and the Vacuum Products division.

ActiveSight, Rigaku’s contract research organization (CRO), servicing the pharmaceutical and biotech markets, will continue to operate as a separate entity. The former Rigaku/MSC operation in the U.K will now be known as Rigaku Europe.

From a legal and formal standpoint, the transition will take place over the next few months, with the completion targeted for March 1, 2006.